DAFTAR PUSTAKA

1. Gout. Dalam: Edisi V Jilid III Buku Ajar Ilmu Penyakit Dalam. Jakarta: Pusat Penerbitan Ilmu
Penyakit Dalam FK UI. 2009.
2. So A. Developments in the scientific and clinical understanding of gout. Arthritis Res Ther, Vol. 10, No 5.
2008. PP.221-27, ISSN 1478-6362.
3. Uric Acid as a Target of Therapy in CKD Diana I. Jalal, MD,1 Michel Chonchol,
MD,1 Wei Chen, MD, PhD,1,2 and Giovanni Targher, MD3
4. The prevalence of hyperuricemia in China: a meta-analysis Liu B1, Wang T1, Zhao
HN1, Yue WW1, Yu HP1, Liu CX1, Yin J1, Jia RY1* and Nie HW2
5. tinah
6. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces
hyperuricosuria and urate nephropathy Frede ric Preitnera,b,1, Olivier Bonnyc,1,
Alexandra Laverrie` reb,d, Samuel Rotmane, Dmitri Firsovc, Anabela Da Costaa,c,
Salima Metrefa,c, and Bernard Thorensb,d,2
7. Causes and Consequences of Chronic Kidney Disease: Implications for Managed
Health Care Daniel E. Weiner, MD, MS
8. Avram Z & Krishnan N. Hyperuricaemia-When Rheumatology meets Nephrology.
Oxford Journal Rheumatology. 2008;47:960964.
9. Convento MS, Pessoa E, Dalboni MA, Borges FT, Schor N. (2011). Pro-
inflammatory and oxidative effects of noncrystalline uric acid in human mesangial
cells: contributionto hyperuricemic glomerular damage. Urological Research, Vol. 39,
No.1, (June 2010), pp.21-27, ISSN 0300-5623
10. Kutzing, MK & Firestein, BL. (2008). Altered uric acid levels and disease states. Journal of
Pharmacology and Experimental Therapeutics, Vol. 324, No 1, (September 2008), pp.1-7, ISSN 0022-
3565.
11. Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension Sanaz
Sedaghat,
12. Shan Y, Zhang Q, Liu Z, Hu X, Liu D. (2010). Prevalence and risk factors associated with chronic kidney
disease in adults over 40 years: a population study from Central China. Nephrology, Vol. 15, No 3, (April
2010), pp.354-61, ISSN 1440-1797
13. Prevalence of Anemia in Chronic Kidney Disease in the United States Melissa E.
Stauffer1*, Tao Fan2 1SCRIBCO, Effort, Pennsylvania, United States of America,
2Merck & Co., Inc., Whitehouse Station, New Jersey, United States of Ameri
14. Hypertension in Chronic KidneyDisease: Navigating
the Evidence F. M. Tedla,1 A. Brar,1 R. Browne,1 and C. Brown1, 2
15. Albertoni G, Maquigussa E, Pessoa E, Barreto JA, Borges F, Schor N. (2010). Soluble uric acid
increases intracellular calcium through an angiotensin II-dependent mechanism in immortalized human
mesangial cells. Experimetal Biological Medicine, Vol. 235, No.7, (July 2010), pp.825-832, ISSN 1535-
3702.
16. Incidence of Chronic Kidney Disease and Its Risk Factors,Results of Over 10 Year
Follow Up in an Iranian Cohort Maryam Tohidi1
17. Adeera levin
18. Sijpkens
19. ROBIN K. DORE, MD Clinical Professor of Medicine, Division of Rheumatology,
David Geffen School of Medicine, University of California at Los Angeles, Los
Angeles, CA The gout diagnosis Staging of Chronic Kidney Disease: Time for a
Course Correction Carolyn Bauer, Michal L. Melamed, and Thomas H. Hostetter
20. The modern management of gout Tom G. Rider1 and Kelsey
M. Jord





1. Association between hyperuricemia and hypertension in a Chinese population at a
high risk of hypertension.Lu ZS1, Lu ZH, Lu H, Yan SG, Wang JA, Li L, You W.
2. Prevalence of Anemia in Chronic Kidney Disease in the United States Melissa E.
Stauffer1*, Tao Fan2 1SCRIBCO, Effort, Pennsylvania, United States of America,
2Merck & Co., Inc., Whitehouse Station, New Jersey, United States of Americ
3. Chronic Kidney Disease and Its Complications Robert Thomas, M.D.1,2, Abbas
Kanso, M.D.1,2, and John R. Sedor, M.D.1,2,3
4. Incidence of Chronic Kidney Disease and Its Risk Factors,Results of Over 10 Year
Follow Up in an Iranian Cohort Maryam Tohidi1
5. Adeera levin
6. Sijpkens
7.